sábado, 18 de junio de 2016

Final Update Summary: Colorectal Cancer: Screening - US Preventive Services Task Force

Final Update Summary: Colorectal Cancer: Screening - US Preventive Services Task Force

The U.S. Preventive Services Task Force released today a final recommendation statement on screening for colorectal cancer. The USPSTF recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years. The decision to screen for colorectal cancer in adults aged 76 to 85 years should be an individual one, taking into account the patient’s overall health and prior screening history. To view the recommendation and the evidence on which it is based, please go to http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/colorectal-cancer-screening2. The final recommendation statement can also be found in the June 15, 2016 online issue of JAMA.

U.S. Preventive Services Task Force banner

U.S. Preventive Services Task Force banner

Colorectal Cancer: Screening

Release Date: June 2016

Recommendation Summary

Population	Recommendation	Grade (What's This?)
Adults aged 50 to 75 years	The USPSTF recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years. The risks and benefits of different screening methods vary. See the Clinical Considerations section and the Table for details about screening strategies.	The USPSTF recommends the service. There is high certainty that the net benefit is substantial.
Adults aged 76 to 85 years	The decision to screen for colorectal cancer in adults aged 76 to 85 years should be an individual one, taking into account the patient’s overall health and prior screening history. Adults in this age group who have never been screened for colorectal cancer are more likely to benefit. Screening would be most appropriate among adults who 1) are healthy enough to undergo treatment if colorectal cancer is detected and 2) do not have comorbid conditions that would significantly limit their life expectancy.	The USPSTF recommends against routinely providing the service. There may be considerations that support providing the service in an individual patient. There is at least moderate certainty that the net benefit is small.